Skip to content

Multicenter Clinical Study for Tissue Engineering Skin Transplantation in the Treatment of Vitiligo

Study for Skin Transplantation in the Treatment of Vitiligo

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027751
Enrollment
Unknown
Registered
2019-11-25
Start date
2017-11-17
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

1:Epidermal transplantation with traditional culture methods + Electric knife grinding
2:Epidermal transplantation with improved culture method + CO2 laser grinding

Sponsors

Huashan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) In patients with stable vitiligo, the stable period is defined as no new skin lesion within at least one year, no enlargement of the original skin lesion and no isomorphic reaction; (2) Aged 18 to 65 years; (3) Other treatment methods are ineffective. (4) Sign informed consent and be willing to undergo surgical treatment

Exclusion criteria

Exclusion criteria: (1) Patients with scar constitution; (2) Patients who cannot cooperate with the operation; (3) Patients with serious medical or infectious diseases who are not suitable for traumatic operation; (4) With serious cardiopulmonary diseases, active infectious diseases and hematological diseases.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy;

Secondary

MeasureTime frame
Adverse Reactions;

Countries

China

Contacts

Public ContactJinhua Xu

Huashan Hospital Affiliated to Fudan University

xjhhsyy@163.com+86 021 52887757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026